SIMPLESTEP IGNITE
LIVE

Serial Number

99564094

Owner

ABCAM LIMITED

Attorney

Christopher M. Kindel

Filing Date

Dec 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SIMPLESTEP IGNITE Trademark

Serial Number: 99564094

SIMPLESTEP IGNITE is a trademark filed by ABCAM LIMITED on December 23, 2025. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ABCAM LIMITED (12 trademarks)

DISCOVERY DRIVE
CAMBRIDGE CB2 0AX , GB

Entity Type: 24

Trademark Details

Filing Date

December 23, 2025

Registration Date

Not Registered

Published for Opposition

September 1, 2026

Goods & Services

Assay kits consisting of chemical reagents and antibodies for in vitro scientific and research use; in vitro immunoassay kits for research laboratory use; chemiluminescent reagents and substrates for laboratory use; chemiluminescence detection assays for scientific research and research laboratory use; enzyme substrates for chemiluminescence assays for scientific research purposes; antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins for scientific research and research laboratory use; cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposes

Providing scientific information relating to assay kits consisting of chemical and chemiluminescent reagents and antibodies, chemiluminescence detection assays, in vitro immunoassay kits for research laboratory use, antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins, cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposes; providing scientific and medical research information on immune response and protocols relating to antibody use; providing scientific information on the selection, production, purification, application, structure and activities of antibodies; providing technical support relating to antibody selection and use, namely, providing technical consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer network

Luminometers and chemiluminescence readers for scientific and laboratory use; downloadable electronic publications in the nature of books, magazines, manuals, guides and technical protocol guides in the field of research, development, technological and user information for use in enhancing assay kits consisting of chemical and chemiluminescent reagents and antibodies, chemiluminescence detection assays, in vitro immunoassay kits for research laboratory use, antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins, cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposes

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 4, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 4, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 4, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 4, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 28, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 15, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 15, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 15, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 27, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 23, 2025 MAFR
NEW APPLICATION ENTERED
Dec 23, 2025 NWAP